Live Breaking News & Updates on Rial Svra Us8051111016

Stay updated with breaking news from Rial svra us8051111016. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Savara Reports First Quarter Financial Results and Provides Business Update

Pivotal Phase 3 IMPALA-2 Trial Remains On-Track

Company expects trial to be fully enrolled in June 2023, on-track to report top line data by end of 2Q 2024

48-week placebo-controlled trial is. | May 15, 2023 ....

Pharma Gmb , Matt Pauls , Savara Inc , Quarter Financial Results , Nebulizer System , Private Securities Litigation Reform Act , Consolidated Statements , Savara Inc Stock Exchange , Press Release , Rial Svra Us8051111016 ,